Home/Filings/4/0001209191-21-016879
4//SEC Filing

Hansen Graydon C. 4

Accession 0001209191-21-016879

CIK 0000718937other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:36 PM ET

Size

38.8 KB

Accession

0001209191-21-016879

Insider Transaction Report

Form 4
Period: 2021-03-01
Hansen Graydon C.
Sr. VP, Global Operations
Transactions
  • Exercise/Conversion

    Common Stock Options

    2021-03-0122922,813 total
    Exercise: $35.98From: 2020-03-14Exp: 2029-03-13Common Stock (229 underlying)
  • Exercise/Conversion

    Common Stock Options

    2021-03-0114,4918,322 total
    Exercise: $35.98From: 2020-03-14Exp: 2029-03-13Common Stock (14,491 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-01$15.25/sh+2,431$37,07323,984 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$16.15/sh+1,218$19,67125,202 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$29.80/sh+374$11,14525,546 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$35.98/sh+229$8,23925,805 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$29.80/sh+5,618$167,41631,423 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$35.98/sh+14,491$521,38645,914 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$16.15/sh+185$2,98846,099 total
  • Sale

    Common Stock

    2021-03-01$103.21/sh20,294$2,094,54425,805 total
  • Sale

    Common Stock

    2021-03-01$103.05/sh11,427$1,177,55214,378 total
  • Exercise/Conversion

    Common Stock

    2021-03-01$16.15/sh+2,069$33,41416,447 total
  • Sale

    Common Stock

    2021-03-01$106.03/sh2,069$219,37614,378 total
  • Exercise/Conversion

    Common Stock Options

    2021-03-012,4310 total
    Exercise: $15.25From: 2018-11-13Exp: 2027-11-12Common Stock (2,431 underlying)
  • Exercise/Conversion

    Common Stock Options

    2021-03-011,2182,602 total
    Exercise: $16.15From: 2019-03-15Exp: 2028-03-14Common Stock (1,218 underlying)
  • Exercise/Conversion

    Common Stock Options

    2021-03-013746,368 total
    Exercise: $29.80From: 2019-06-14Exp: 2028-06-13Common Stock (374 underlying)
  • Exercise/Conversion

    Common Stock Options

    2021-03-015,618750 total
    Exercise: $29.80From: 2019-06-14Exp: 2028-06-13Common Stock (5,618 underlying)
  • Exercise/Conversion

    Common Stock Options

    2021-03-011852,417 total
    Exercise: $16.15From: 2019-03-15Exp: 2028-03-14Common Stock (185 underlying)
  • Exercise/Conversion

    Common Stock Options

    2021-03-012,069348 total
    Exercise: $16.15From: 2019-03-15Exp: 2028-03-14Common Stock (2,069 underlying)
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $105.34, inclusive.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.36, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.14, inclusive.
  • [F4]The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021.
  • [F5]The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2023.

Issuer

STAAR SURGICAL CO

CIK 0000718937

Entity typeother

Related Parties

1
  • filerCIK 0001781933

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:36 PM ET
Size
38.8 KB